[1]
Mahallawi, W. 2026. Novel bivalent mucosal antigen formulation targeting SARS-CoV-2 and influenza: immunogenicity assessment using zan in vitro human nasal-associated lymphoid tissue model. Polish Journal of Veterinary Sciences. 29, 2 (Jun. 2026), 281–289. DOI:https://doi.org/10.24425/pjvs.2026.1273.